Please check your internet connection and try again.
# Walethmade 25%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525250 bromide
## Overview
Walethmade bromide (potassium bromide) is an anticonvulsant medication with a well-established history. It is often used as an adjunct therapy in specific seizure types.
## Primary Indications
Adjunctive treatment of refractory seizures, particularly generalized tonic-clonic and focal seizures, in dogs. Its use in other species or as a first-line agent is less common.
## Adult Dosing
The exact dosing regimen for Walethmade bromide is highly dependent on the specific animal's weight, metabolic rate, and response to therapy. Dosing is typically initiated slowly and titrated upwards.
* **Loading Dose:** Often administered over several days to reach therapeutic serum concentrations more rapidly. For example, a loading dose might be 200-400 mg/kg divided into 2-3 daily doses.
* **Maintenance Dose:** Typically 10-20 mg/kg once or twice daily. The dose may be adjusted based on seizure control and serum bromide concentrations.
Local protocols and veterinary guidance are essential for determining precise dosing.
## Pediatric Dosing
Information on pediatric dosing is not well-established or commonly reported. Dosing in juvenile animals would require careful titration and monitoring, similar to adults, with consideration for growth and development.
## Dose Adjustments
Dose adjustments are primarily guided by therapeutic drug monitoring (serum bromide levels) and clinical response (seizure frequency and severity).
* **Renal Impairment:** While generally considered safe in animals with renal impairment, doses may need to be reduced and serum bromide levels closely monitored due to potential for accumulation.
## Contraindications
* Known hypersensitivity to bromide salts.
## Adverse Effects
Common adverse effects include sedation, ataxia, polyuria, polydipsia, polyphagia, and gastrointestinal upset (vomiting, constipation). Less common but serious effects can include pancreatitis and hyperthermia.
## Key Drug Interactions
* **Phenobarbital:** Co-administration with phenobarbital can lead to increased serum bromide levels, requiring dose adjustments of one or both drugs. Phenobarbital can also induce hepatic metabolism of bromide.
* **Other CNS Depressants:** Additive sedative effects may occur.
## Monitoring
* **Serum Bromide Concentration:** Regularly monitor serum bromide levels to ensure they are within the therapeutic range (typically 1000-2000 mg/L, though target ranges can vary). Levels should be checked after achieving steady-state (usually 3-4 months after initiating maintenance therapy or after dose changes).
* **Clinical Efficacy:** Assess for reduction in seizure frequency and severity.
* **Adverse Effects:** Monitor for signs of toxicity, including neurological, gastrointestinal, and behavioral changes.
* **Renal and Hepatic Function:** Baseline and periodic monitoring may be warranted, especially in animals with pre-existing conditions or on long-term therapy.
## Clinical Pearls
* Walethmade bromide has a long half-life, meaning it takes time to reach steady-state concentrations.
* It is often used in conjunction with other anticonvulsants, most commonly phenobarbital, for synergistic effects.
* Sudden withdrawal can precipitate seizures.
* Ensure adequate hydration and diet, as dietary chloride can affect bromide absorption and excretion.
***
**Disclaimer:** This information is intended for clinical pharmacists and veterinary professionals. It is essential to consult the most current prescribing information, veterinary literature, and local institutional protocols for complete and up-to-date guidance. Dosing and management decisions should always be individualized and made by a qualified veterinarian.
